Certificate of Analysis
Purity
≥98.0%
Method
HPLC / MS
Testing
Third-Party
COA Status
Available
Survodutide
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Choose Pack Size
Quantity
Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
About Survodutide
Survodutide (BI 456906) is a synthetic peptide dual agonist designed to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). The molecule incorporates structural elements of both GLP-1 and glucagon pharmacophores within a single peptide backbone, along with a fatty acid modification strategy for extended plasma half-life via albumin binding. Unlike tirzepatide (which also includes GIP-R activity), survodutide focuses on the GLP-1R/GCGR axis, representing a mechanistically distinct dual agonist structural class.
In laboratory research, survodutide has been investigated for its comparative receptor activation potency and selectivity at GLP-1R versus GCGR in cell-based assay systems, the downstream cAMP signaling kinetics resulting from dual receptor engagement, and its pharmacological profile relative to selective single-receptor agonists. Scientific interest centers on the ability to rationally balance agonist activity between two receptors with opposing physiological functions and on characterizing the receptor-level consequences of such balanced dual agonism. This compound is for qualified research use only.
Peptide / Compound Information
| Property | Value |
|---|---|
| Peptide Sequence | GLP-1/Glucagon dual receptor agonist peptide with fatty acid albumin-binding modification |
| Molecular Formula | Complex modified peptide |
| Molecular Weight | ~4,969 g/mol |
| CAS Number | 2413069-78-0 |
| Synonyms | BI 456906, GLP-1/Glucagon Dual Agonist |
Lyophilized Research Peptides
This product is supplied in lyophilized (freeze-dried) form — a process that extends shelf life and preserves peptide purity and structural integrity during storage. No fillers, excipients, or preservatives are used in the lyophilization process. The lyophilized powder should be reconstituted with an appropriate research-grade solvent in a controlled laboratory environment prior to use in in vitro or preclinical assay systems.
99%+
PURITY
Third Party Tested
Independently verified by ISO-accredited laboratories. Batch-specific COAs available on request.
GMP
CERT.
GMP Manufacturing Standards
Synthesized in registered facilities following Good Manufacturing Practices with full chain-of-custody documentation.
FAST
SHIP
Best in Class Fulfillment
Same-day fulfillment on qualifying orders. Secure cold-chain packaging. Domestic and international research shipping.
ZERO
FILLERS
Zero Fillers or Additives
Pure active compounds only. Lyophilized without fillers or preservatives. Composition independently verified.
Scientific Content Review
All technical product descriptions, molecular data, and research context on this page have been prepared with reference to published scientific literature and PubChem compound databases. Content is intended for informational purposes in a research catalog context and does not constitute medical advice or claim therapeutic efficacy.
Survodutide is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.
Category
GLP-1 / Metabolic
Purity
≥98.0%
Available Sizes
10MG
COA
Available